FDA’s Human Drug Compounding Progress Report Jan 2017

February 7, 2017

Just over three years ago, on November 27, 2013, Congress amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) by enacting the Drug Quality and Security Act (DQSA). The first title of the DQSA, known as the Compounding Quality Act, was passed in response to numerous serious adverse events, including deaths, linked to poor […]

Read more

New Look… Same Great Service.

September 13, 2016

AmerisourceBergen’s acquisition of PharMEDium brings together two great brands with strongly aligned values in patient safety and quality.

Read more

AmerisourceBergen’s acquisition of PharMEDium Services brings together two great brands with strongly aligned core values in patient safety and quality.

September 12, 2016

To Our Valued Customers: AmerisourceBergen’s acquisition of PharMEDium Services brings together two great brands with strongly aligned core values in patient safety and quality. New, Refreshed Logo Over the next few months, PharMEDium’s labeling and packaging will be updated to incorporate a new and refreshed logo. The new logo visually aligns PharMEDium with our parent […]

Read more

PharMEDium Announces Sole Source Agreement with Premier, Inc.

February 9, 2016

PharMEDium Services, LLC, a part of AmerisourceBergen, announced the renewal of its sole source group purchasing agreement with Premier, Inc. to continue providing outsourced pharmacy compounding and admixture services to Premier member facilities through December 2018.

Read more

PharMEDium Earns Prestigious Center of Excellence Recognition from BenchmarkPortal

January 4, 2016

PharMEDium Services, LLC, a part of AmerisourceBergen, announced the recent certification of its Customer Service Center as a Center of Excellence by BenchmarkPortal. The Center of Excellence recognition is one of the most prestigious awards in the customer service and support industry.

Read more

AmerisourceBergen to Acquire PharMEDium Healthcare Holdings, Inc.

October 6, 2015

AmerisourceBergen (NYSE:ABC) today announced that it has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held leading national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals in the United States, from Clayton, Dubilier & Rice for $2.575 billion in cash, subject to certain adjustments and on a cash-free, debt-free basis.

Read more

Rich Kruzynski’s Guest Editorial in Pharmacy Practice News: ‘Survival of the Fittest’ for Outsourcing Facilities

April 8, 2014

See PharMEDium President Rich Kruzynski's Guest Editorial ‘Survival of the Fittest’ for Outsourcing Facilities

Read more

Important Labeling Changes to Inner and Outer Cartons

March 14, 2014

PharMEDium is registered with the U.S. Food and Drug Administration (FDA) as a 503B large-scale sterile compounding "outsourcing facility" under the recently enacted Drug Quality and Security Act (DQSA).

Read more

PharMEDium Supports NPSF National Patient Safety Week

March 2, 2014

Patient Safety Awareness Week is an annual education and awareness campaign for health care safety led by NPSF (National Patient Safety Foundation).

Read more

FDA Outreach Implementation of Drug Quality and Security Act (HR 3204)

January 9, 2014

The President signed the Drug Quality and Security Act (DQSA) into law on November 27, 2013. Title I of DQSA, the Compounding Quality Act, includes important provisions relating to the oversight of compounding of human drugs.

Read more
In-House vs Outsourced Compounding